Xiangxue Pharmaceutical Co.,Ltd. (300147.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap6B
Enterprise Value7.22B
P/E Ratio-8.95
PEG Ratio-0.3
Price/Sales Ratio3.02
Price/Book Ratio-9.75
Enterprise/Revenue3.87
Enterprise/EBITDA-7.95

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.93
Operating Margin-0.51
AD

Management Effectiveness

Return On Assets-0.21
Return On Equity-8.31

Income Statement

Revenue1.6B
Revenue/Share2.31
Gross Profit435.94M
EBITDA113.65M
Net Income-1.39B
Diluted EPS-2.11

Balance Sheet

Total Cash144.74M
Total Cash/Share0.22
Total Debt1.44B
Total Debt/Equity-3.05
Current Ratio0.24
Book Value Per Share-0.13

Price History

52-Week Change-11.98
52-Week High12.79
52-Week Low5.9
Moving Average 50 Days8.73
Moving Average 200 Days9.44

Statistics

Average Volume11.32M
Shares Outstanding658.72M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0
Last Split Factor151:125
Last Split DateJune 18, 2015
AD